If the FDA restricts compounded GLP-1 production, raw materials become unavailable, or the company discontinues the program, the service could end, with members given notice to seek alternative providers
Mention it to your prescribing clinician promptly
Addiction treatment and GLP-1 In 2024, researchers at Oklahoma State University led the first-ever case study on the effects of a type of GLP-1, called semaglutide, for use in treating alcohol addiction
This practice allows doctors to support innovation by participating in research and consulting with companies, helping to shape new treatments and technologies based on the needs of their patients
Some peptides, including retatrutide, can cause side effects such as nausea, vomiting, fatigue, or digestive issues
Under the Bridge, Part D plan sponsors carry zero financial risk CMS funds this directly